Possible C Share Issue
As at 28 March 2014 the ordinary shares traded at a premium to the prevailing
cum income NAV of 5.1%, as compared to an average discount for the UK Growth
and Income sector of 1.5%.
Taking into account the Company's performance since IPO, the current rating of
its shares, and the Manager's outlook for potential investee companies and the
Company's underlying portfolio, the Board is considering increasing the
Company's capital base through a pre-emptive offer of C Shares to raise up to
approximately £50 million of gross proceeds in June 2014. Any such fundraising
would be expected to reduce the Company's Ongoing Cost ratio as well as broaden
the Company's investor base to improve market liquidity for existing
Shareholders.
The Company is taking legal, tax and financial advice and will make a further
announcement in due course.
Contact details:
Miton Group plc:
Gervais Williams Gervais.williams@mitongroup.com 0203 714 1516
Martin Turner Martin.turner@mitongroup.com 0203 714 1517
David Barron David.barron@mitongroup.com 0203 714 1474
Cenkos Securities plc:
Dion Di Miceli ddimiceli@cenkos.com 020 7397 1921
Sapna Shah sshah@cenkos.com 020 7397 1922
Chris Lunn clunn@cenkos.com 020 7397 1912
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.